{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:17:23Z","timestamp":1649182643285},"reference-count":32,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.regpep.2012.08.007","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T23:45:23Z","timestamp":1346802323000},"page":"10-14","source":"Crossref","is-referenced-by-count":9,"title":["Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury"],"prefix":"10.1016","volume":"179","author":[{"given":"Sabrina","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Eisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Karrasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus N.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampos","family":"Aslanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2012.08.007_bb0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1478-3231.2005.01163.x","article-title":"Portal hypertension: from pathophysiology to clinical practice","volume":"25","author":"Laleman","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.regpep.2012.08.007_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","article-title":"Liver cirrhosis","volume":"25","author":"Pinzani","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","article-title":"Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases","volume":"28","author":"Gressner","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.regpep.2012.08.007_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/1354750X.2011.561366","article-title":"Connective tissue growth factor (CTGF\/CCN2) ELISA: a novel tool for monitoring fibrosis","volume":"16","author":"Dendooven","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.regpep.2012.08.007_bb0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jhep.2007.05.015","article-title":"Differential effects of TGF-beta on connective tissue growth factor (CTGF\/CCN2) expression in hepatic stellate cells and hepatocytes","volume":"47","author":"Gressner","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1600-0676.2000.020004296.x","article-title":"Connective tissue growth factor in human liver cirrhosis","volume":"20","author":"Abou-Shady","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.regpep.2012.08.007_bb0035","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1478-3231.2007.01608.x","article-title":"Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C","volume":"28","author":"Hora","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.regpep.2012.08.007_bb0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0168-8278(00)80244-5","article-title":"Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells","volume":"32","author":"Williams","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/diacare.27.5.1164","article-title":"Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy","volume":"27","author":"Roestenberg","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.08.007_bb0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1006\/bbrc.1998.9543","article-title":"Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia","volume":"251","author":"Tamatani","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2012.08.007_bb0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10620-009-0781-9","article-title":"The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis","volume":"55","author":"Zhang","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2012.08.007_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/vim.2009.0067","article-title":"The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis","volume":"23","author":"Guo-Qiu","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0065","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3748\/wjg.v18.i18.2280","article-title":"Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis","volume":"18","author":"Piao","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0070","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1373\/clinchem.2006.070466","article-title":"Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis","volume":"52","author":"Gressner","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.regpep.2012.08.007_bb0075","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2893.2009.01110.x","article-title":"Validation of connective tissue growth factor (CTGF\/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis","volume":"16","author":"Kovalenko","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.regpep.2012.08.007_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12072-008-9100-3","article-title":"Pathogenetic background for treatment of ascites and hepatorenal syndrome","volume":"2","author":"Moller","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.regpep.2012.08.007_bb0090","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.08.007_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM199401203300303","article-title":"The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding","volume":"330","author":"Rossle","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.08.007_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","article-title":"Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function","volume":"55","author":"Wanninger","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.regpep.2012.08.007_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MEG.0b013e328343700a","article-title":"Portal levels of latent transforming growth factor-beta are related to liver function in patients with liver cirrhosis","volume":"23","author":"Wanninger","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0110","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","article-title":"Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes","volume":"95","author":"Weigert","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.08.007_bb0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","article-title":"Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes","volume":"72","author":"Weigert","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.regpep.2012.08.007_bb0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cyto.2010.06.013","article-title":"Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis","volume":"53","author":"Wiest","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.regpep.2012.08.007_bb0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2008-1040325","article-title":"Assessment of prognosis of cirrhosis","volume":"28","author":"Durand","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.regpep.2012.08.007_bb0130","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","article-title":"Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status","volume":"51","author":"Wadhawan","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2012.08.007_bb0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.regpep.2012.08.007_bb0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3748\/wjg.v17.i2.151","article-title":"Connective tissue growth factor reacts as an IL-6\/STAT3-regulated hepatic negative acute phase protein","volume":"17","author":"Gressner","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0145","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.yexmp.2011.09.006","article-title":"Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis","volume":"91","author":"Walter","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.regpep.2012.08.007_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","article-title":"The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis","volume":"50","author":"Weng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.regpep.2012.08.007_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11011-008-9122-5","article-title":"Interorgan ammonia trafficking in liver disease","volume":"24","author":"Olde Damink","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.regpep.2012.08.007_bb0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.510290302","article-title":"Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis","volume":"29","author":"Lotterer","year":"1999","journal-title":"Hepatology"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512002236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512002236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T02:28:36Z","timestamp":1542767316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011512002236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":32,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0167011512002236"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2012.08.007","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}